Clinical outcomes of KeraVio using violet light: emitting glasses and riboflavin drops for corneal ectasia: a pilot study

BACKGROUND/AIMS: We developed a novel technology consisting of violet light (VL)-emitting glasses and defined the combination of VL irradiation and riboflavin treatment as KeraVio. Our goal was to evaluate the clinical results of KeraVio in patients with progressive corneal ectasia. METHODS: Eyes we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobashi, Hidenaga, Torii, Hidemasa, Toda, Ikuko, Kondo, Shinichiro, Itoi, Motozumi, Tsubota, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479745/
https://www.ncbi.nlm.nih.gov/pubmed/32892163
http://dx.doi.org/10.1136/bjophthalmol-2020-316974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479745/
https://www.ncbi.nlm.nih.gov/pubmed/32892163
http://dx.doi.org/10.1136/bjophthalmol-2020-316974

Ejemplares similares